A tranq wound is a skin ulcer caused by xylazine, a veterinary sedative that has become a common adulterant in the illicit drug supply, particularly in fentanyl. These wounds are distinctive because they involve deep, slow-healing tissue death that can progress from small sores to large open ulcers exposing muscle or bone. They’ve become a growing public health concern, especially in cities like Philadelphia, where xylazine contamination is widespread.
Why Xylazine Causes Skin Wounds
Xylazine, often called “tranq” or “tranq dope” when mixed with fentanyl, is a sedative and pain reliever approved only for animals. It is not an opioid, but it’s frequently blended into the opioid supply because it can extend fentanyl’s effects. Many people are exposed to it unknowingly, and some who use drugs have told researchers it’s an unwanted additive they didn’t choose.
The wounds happen because xylazine constricts blood vessels, reducing blood flow to the skin. With less blood reaching the tissue, oxygen delivery drops. At the same time, xylazine lowers blood pressure, heart rate, and breathing, which further starves the skin of oxygen. Over time, repeated exposure compounds this effect: tissue that isn’t getting enough oxygen begins to die, and the resulting wounds struggle to heal because the same reduced blood flow that caused them also prevents the body from repairing the damage. Decreased circulation makes it harder for immune cells to reach the wound, increasing the risk of infection.
One of the most unusual features of tranq wounds is that they can appear far from the actual injection site, or even in people who don’t inject drugs at all. A person might inject in one location and develop ulcers on a different limb entirely. The exact reasons for this aren’t fully understood, but the systemic effects of xylazine on blood flow likely play a role. This sets tranq wounds apart from typical injection-related skin injuries, which occur at the point where a needle enters the skin.
What Tranq Wounds Look Like
Tranq wounds progress through recognizable stages. Early on, they appear as small, shallow ulcers with a dry, dark crust of dead tissue called eschar. There’s redness around the edges, but no deeper tissue damage yet.
As the wound worsens, it develops areas of active tissue death alongside patches of new, raw-looking tissue (granulation tissue) and bleeding. At this stage, wounds are typically smaller than the palm of a hand. Left untreated, they can grow larger than 10 centimeters across, with widespread dead tissue scattered among areas of bleeding and new growth.
In the most severe cases, wounds deepen enough to expose tendons, muscle, or even bone. These advanced wounds often produce pus, and in extreme situations, maggot infestation has been documented. One defining characteristic across all stages is that tranq wounds tend to develop significant eschar early and lack the swelling typical of other wound types. They present as dry, necrotic tissue rather than inflamed, puffy skin.
Why These Wounds Heal So Slowly
Tranq wounds are notoriously difficult to heal, and the reasons go beyond the direct damage xylazine causes. The drug’s blood vessel constriction limits the body’s ability to grow new blood vessels in the wound area and blocks immune cells from reaching the site to fight infection and begin repair. When xylazine is combined with fentanyl, the problem gets worse. Opioids suppress the function of key immune cells called macrophages, which are responsible for clearing damaged tissue and jumpstarting the healing process. The combination effectively attacks wound healing from multiple angles: reduced blood flow, impaired immune response, and limited cell migration to the injury.
Withdrawal adds another layer of difficulty. Xylazine withdrawal causes significant anxiety and physical distress, which can make it harder for people to consistently care for their wounds or access medical treatment. The cycle of use and withdrawal creates conditions where wounds rarely get the sustained, uninterrupted healing time they need.
How Tranq Wounds Are Treated
The foundation of tranq wound care is removing dead tissue, a process called debridement. Dead tissue harbors bacteria and blocks healing. There are several approaches, ranging from simple to surgical. The gentlest method is keeping the wound moist so the body’s own enzymes gradually break down dead tissue. This is something people can do on their own with basic supplies. Prescription options include topical treatments that use enzymes to dissolve dead tissue, though these work poorly on thick, dry eschar without additional preparation. For wounds with exposed bone or tendon, surgical removal of dead tissue under anesthesia is typically necessary.
Basic wound care follows a straightforward routine:
- Clean wounds with plain soap and warm water, or saline. Never use alcohol or hydrogen peroxide, which kill healthy cells and dry out the wound.
- Apply petroleum-based ointment to a clean bandage, then place it on the wound.
- Wrap lightly with dry bandages, just enough to stay in place without pressing into the skin.
- Change bandages every two to three days, or daily when possible.
Keeping wounds moist is critical. Dry wounds heal more slowly and develop thicker eschar. One practical tip from public health guidance: drawing a circle around each wound with permanent marker helps track whether it’s shrinking or growing over time, since progress can be so gradual it’s hard to notice day to day.
Amputation and Severe Outcomes
When tranq wounds go untreated or progress to deep tissue involvement, amputation can become necessary. A study of over 12,000 patients with opioid use disorder in Philadelphia found that amputation rates nearly doubled between 2018 and 2023, rising from 0.81% to 1.55% of acute care visits. The odds of amputation were roughly twice as high in 2022 and 2023 compared to 2018 and 2019, a trend that tracks closely with the rise of xylazine in the drug supply.
While the overall percentage remains relatively low, the doubling in just five years reflects the growing severity of xylazine-related wounds in communities where the drug is prevalent. Early wound care, even basic cleaning and covering, can make a significant difference in preventing progression to the point where amputation becomes the only option.